Parkinson's Disease

Parkinson's Disease

What is Parkinson’s Disease?

Parkinson’s Disease is a condition in which parts of the brain become progressively damaged over many years. People with Parkinson’s don’t have enough of a chemical called dopamine because some nerve cells in their brain have died.

CED and Parkinson’s Disease

The CED system was designed and is today administered by Professor Gill and his team in the UK as part of a treatment plan for Parkinson’s. Through its founder Bryn Williams, Funding Neuro advocated for a clinical trial which began in 2013.

This ground breaking phase 1 trial involved six patients with Parkinson’s Disease, delivering a growth factor called GDNF (Glial Cell Line- Derived Neutrophic Factor). It resulted in the complete reversal of the disease in all six patients.

A phase 2 study closed in 2016 with equally exceptional results.

There is a phase 3 planned – the next step towards the treatment becoming widely available. Phase 3 of a clinical trial aims to prove how effective the new treatment is, in comparison with current ‘gold standard’ treatments for a condition.

Symptoms of Parkinson’s Disease

Symptoms and the rate at which the condition progresses vary from individual to individual. Whilst every person with Parkinson’s Disease experiences their symptoms differently, the three main symptoms are:

  • Involuntary shaking of particular parts of the body (tremor)
  • Slow movement
  • Stiff and inflexible muscles (rigidity)

Other physical and psychological symptoms may include:

Statistics

  • Scientists believe that around 1 in 500 people are affected by Parkinson’s disease. There are an estimated 127,000 people in the UK living with the condition.
  • Most people with Parkinson’s start to develop symptoms when they’re over 50. However, around 1 in 20 people with the condition first experience symptoms when they’re under 40.

Our founder Bryn Williams was diagnosed with Young Onset Parkinson’s at the age of 36.  Read more about Bryn’s story and his response to his diagnosis.

For the majority of people, Parkinson’s Disease will not significantly affect their life expectancy.

Treatments for Parkinson’s Disease

Further support

Please contact us at Funding Neuro with any further questions or concerns. We do not offer support or bereavement counselling, but our staff are experts in Parkinson’s Disease and can often guide you on best options or put you in touch with other organisations who can further help.

Our esteemed supporters
Funding Neuro supporter